Clinical Trials
-
Understanding and Diagnosing Allergic Disease in Twins
The purpose of this study is to gain better understanding of how the immune system works intwins with and without allergic disease. Healthy volunteers are not specifically targeted.Healthy non-allergic study participants may be found through the course of evaluation forthe presence of allergies.
Investigator
Now accepting new patients View Details -
Peanut Reactivity Reduced by Oral Tolerance in an Anti-IgE Clinical Trial
The investigators will perform a double blind, placebo controlled clinical trial with Xolair(omalizumab) at four centers to safely and rapidly desensitize patients with severe peanutallergy. The investigators will determine if pretreatment with anti-IgE mAb(Xolair/omalizumab) can greatly reduce allergic reactions and allow for faster and saferdesensitization.
Investigator
Now accepting new patients View Details -
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
The objectives of this dose-finding study for the treatment of peanut allergy are:
- To determine the efficacy of 3 doses of Viaskin Peanut (50 mcg ,100 mcg and 250 mcgpeanut protein per patch) to significantly desensitize peanut-allergic subjects topeanut after 12 months of treatment.
- To evaluate the safety of a long-term treatment with Viaskin Peanut.Investigator
Now accepting new patients View Details
Please see a full listing of Stanford's clinical trials here.
Use the ClinicalTrials.gov directory to search among all government-funded clinical trials.